← All indications
Ehlers-Danlos Syndrome
A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.
Subtype terms (1)
More specific conditions that are subtypes of Ehlers-Danlos Syndrome in the MeSH hierarchy.
Drugs by status
Phase 4 trials (4)
Phase 3 trials (3)
Phase 2 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Other Experimental Indications (2)